查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1856327

粘合剂添加剂市场按类型、应用、形态和等级划分 - 全球预测 2025-2032

Binders Excipients Market by Type, Application, Form, Grade - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，粘合剂添加剂市场规模将达到 42.4 亿美元，复合年增长率为 9.93%。

关键市场统计数据
基准年 2024 19.9亿美元
预计年份：2025年 21.8亿美元
预测年份 2032 42.4亿美元
复合年增长率 (%) 9.93%

粘合剂辅料的策略方向，概述了粘合剂辅料在产品性能、可生产性和供应链韧性方面的多方面作用

粘合剂辅料能够维持口服固体製剂和日益增长的营养补充品产品的机械完整性、可生产性和患者疗效。这些材料的功能远不止于简单的黏合；它们还能调节粉末的流动性、可压缩性、崩坏行为以及在各种加工条件下的稳定性。随着配方日益复杂，製程强化也日益标准化，了解黏合剂的功能对于配方科学家和采购负责人都至关重要。

在製药和营养保健品领域，粘合剂从早期研发到商业化都对製剂的选择起着至关重要的作用。聚合物粘合剂与传统淀粉基黏合剂的选择会影响下游加工过程、压片速度，甚至包衣性能。因此，粘合剂的选择会影响品质设计框架、监管策略和成本控制。所以，评估黏合剂不仅要考虑其组成和等级，还要考虑其与活性成分、辅料和加工过程的相互作用。

材料科学和监管要求的最新变化导致人们对辅料的特性、可追溯性和供应商管治的审查日益严格。同时，连续加工和直接压片等生产模式也对粘合剂的性能提出了新的功能性要求。本文将粘合剂辅料定位为策略性类别，其选择和供应链管理对产品性能、上市时间和营运韧性有显着影响。

技术创新、监管透明度和供应链韧性如何重塑粘合剂辅料的选择和供应商策略

技术、监管和供应链的动态变化正在重塑粘合剂辅料的模式。聚合物化学和功能性淀粉改质技术的进步，使得粘合剂能够提供可客製化的释放曲线、更高的可压缩性和更低的润滑剂敏感性。同时，连续直接压片和高通量压片等生产製程的创新，也对黏合剂提出了更高的要求，即需要具有可预测流变性和稳定製程窗口的粘合剂。

监管机构对辅料来源的透明度和可追溯性提出了更高的要求，促使供应商加大投入，完善文件记录、加强材料特性控制并进行第三方检测。同时，对杂质谱和萃取物的审查力度也不断加大，加速了製药业对特性更明确的辅料等级的采用。因此，儘管不同地区的监管制度有所差异，但药用级辅料和营养保健品级辅料之间的界限在实践中变得越来越清晰。

供应链韧性已成为关键因素。供应链中断凸显了多元化筹资策略和供应商风险评估架构的必要性，这些策略和框架不仅限于价格和前置作业时间。负责人正在重新评估合同，筛选二手讯息，并寻求与能够展现生产能力、品质系统和物流可靠性的供应商建立长期战略伙伴关係。这些因素共同作用，正在重塑配方师和采购团队评估粘合剂选择的方式，使他们在优先考虑功能性能的同时，也重视法规遵循和供应连续性。

评估关税调整和贸易政策转变将如何改变装订机供应链的采购行为、供应商多元化和库存策略。

关税措施和贸易政策调整的推出将对粘合剂辅料生态系统产生深远影响，波及原料成本、供应商筹资策略和库存计画。关税往往会增加进口辅料的成本，迫使製造商重新评估其供应商网路并考虑在地采购方案。如果关税出现不可预测的成长，则需要更频繁地审查合约条款、前置作业时间和总到岸成本计算。

为应对关税主导的成本压力，製造商通常会透过供应商多元化来应对，纳入国内生产商和自由贸易区合作伙伴，以减轻关税的影响。虽然这种重组可以提高抗风险能力，但如果替代供应商采用不同的生产技术或原料，也可能导致辅料特性出现差异。因此，配方团队必须投入资源进行过渡性开发活动和等效性测试，以确保替代不会影响片剂的完整性、溶出性能或稳定性。

关税也影响库存策略。企业可能会选择策略性地储备关键粘合剂等级，以应对短期成本波动，但这会带来额外的营运成本和仓储成本，以及保质期管理方面的压力。同时，采购部门正在重新谈判长期合同，并与供应商探讨避险机制，以缓解关税不确定性的影响。这些调整的累积效应凸显了在不断变化的贸易环境下，企业需要进行商业性和技术决策的整合，以维持产品品质和利润率。

利用整合的细分洞察，将黏合剂化学、应用方法、物理形态和品质等级相匹配，从而支持配方和采购决策。

对黏合剂细分的深入理解对于协调配方目标、生产平台和法规遵循至关重要。在考虑基于类型的选择时，配方师会根据各种材料独特的功能特性进行评估，例如藻酸盐、纤维素衍生物、树胶和凝胶、聚乙烯吡咯烷酮、淀粉以及醣类和多元醇。藻酸盐具有独特的水合和凝胶化行为，有利于控制释放应用；纤维素衍生物因其稳定的压缩性和成膜能力而备受青睐。聚乙烯吡咯烷酮也具有很强的干膜和溶液黏合性能，使其适用于多种生产方法。淀粉仍然是一种用途广泛的基准粘合剂，具有明显的成本和生物降解性优势；而醣类和多元醇通常在特定剂型中兼具粘合剂和调味辅料的双重作用。

按应用领域进行细分会影响黏合剂的选择和预期性能。直接压片需要粘合剂能够确保片剂的流动性、可压缩性和强度，而无需额外的製粒步骤；而干式製粒则需要能够承受压缩力并最大限度降低脆碎性的材料。湿式製粒引入了更多标准，因为粘合剂的溶解度、干燥特性以及与活性成分的相互作用都会影响颗粒品质和后续加工。口服固态剂型包括胶囊和锭剂，每种剂型都有其独特的崩坏和稳定性要求。胶囊着重于黏合剂与填充材的相互作用以及胶囊壳的完整性，而片剂则着重于压片动态和包衣相容性。

剂型的选择——粘合剂或液体粘合剂——会进一步影响研发路径和设备选择。干粉黏合剂易于溶解于粉末混合物中，简化了连续生产过程中的操作，但需要严格控製粒径和水分含量。液体粘合剂常用于湿式製粒，以实现快速製粒和均匀分布，但需要考虑溶剂处理和干燥问题，这会影响製程产量和成本。最后，营养保健品级和药品级黏合剂之间的差异会影响文件编制、品质系统和供应商资质认证的负担。药品级黏合剂需要严格的杂质控制、可靠的可追溯性以及符合药典规范，而营养保健品级材料则具有更大的灵活性，但需要确保消费品的功能性能稳定可靠。

跨越这些细分市场需要跨部门协作。製剂科学家必须与采购、品质和法规团队合作，确保黏合剂的选择既满足技术目标，又符合供应商的能力和合规承诺。等效性研究、小规模製程表征和有记录的供应商审核是管理不同类型、应用、剂型和等级产品交叉的实用工具，有助于制定一致的开发和生产计划。

区域动态影响美洲、欧洲、中东和非洲以及亚太市场的黏合剂采购、法规遵循和製造伙伴关係关係

区域动态对粘合剂的采购、监管预期和生产策略有显着影响。在美洲，成熟的製药产业丛集将先进的生产能力与完善的法律规范相结合，从而促进了供应商和製造外包之间的密切合作。北美市场重视供应链透明度和严格的品管体系，并倾向选择能够展现长期生产能力和技术支援的供应商。拉丁美洲国家则呈现不同的动态，本地化生产不断增长，对价格可负担性和供应安全性的日益重视，迫使跨国公司相应地调整其采购和分销策略。

欧洲、中东和非洲的监管协调和严格的药典标准对辅料的文檔和可追溯性提出了高标准。欧洲市场通常在采用永续性标准和更严格的杂质控制方面处于领先地位，促使供应商投资于环保生产实践和更先进的分析表征技术。虽然中东和非洲部分地区仍然依赖进口来获取特种粘合剂，但区域中心和自由贸易区的兴起正在缩短邻近市场的前置作业时间和降低关税风险。这些区域差异要求供应商和製造商调整技术文件和物流安排，以满足独特的监管和商业需求。

亚太地区市场成熟度各异，同时拥有大规模的生产能力和创新的原料加工技术。该地区是传统和新型黏合剂化学品的主要生产商所在地，为全球供应链提供具有成本竞争力的选择，并加速了生物聚合物和改性淀粉技术的区域创新。各地区的法律规范差异显着，在亚太地区营运的公司必须应对不同的註册要求、标准和进口限制。这些区域特征共同影响着公司如何优先考虑供应商资格、技术支援和本地生产伙伴关係，以实现成本效益和合规性。

透过具竞争力的供应商策略，结合技术合作、严格的品质系统和永续性资质，建立成功的配方和采购伙伴关係。

如今，粘合剂供应商之间的竞争动态主要围绕着技术服务、品质保证和供应可靠性这三者。领先的製造商透过投资分析能力（例如颗粒表征、流变分析和稳定性测试）来脱颖而出，从而支援复杂的配方开发并证明产品的可比性。提供应用实验室和共同开发服务的供应商则可协助客户缩短开发週期，并在新材料认证或更换供应商时降低风险。

品质系统和监管文件是至关重要的竞争因素。拥有全面分析证书、完善的变更控制流程和可验证的供应商审核的公司，更有可能赢得与要求可追溯性和合规性的製药公司签订的长期合约。同时，能够提供从营养保健品到药品等多种等级产品，并具有清晰品质区分的公司，更有利于服务多元化的客户群。策略伙伴关係和长期供应协议日益普遍，反映出客户对可预测的前置作业时间和紧急计画的需求。

永续性和企业责任是新的竞争优势。采用更环保的生产流程、减少溶剂使用并展现负责任的植物和淀粉原料采购方式的供应商，将吸引那些将环境因素纳入采购决策的客户。随着采购机构加强对供应商的风险管理和环境考量，能够将技术绩效与永续性资格结合的公司将获得竞争优势。此外，对于希望服务全球客户的供应商而言，能够扩大生产规模以支援小批量创新和大量商业供应的能力仍然至关重要。

管治可采取切实可行的策略步骤，以协调技术能力、供应商多元化和治理框架，从而确保装订机的供应和产品品质。

产业领导者应优先考虑整合策略，将技术开发、供应商多元化和监管回应协调一致。这首先要实施跨职能的粘合剂管治框架，将配方科学家、品质保证、采购和法规事务部门纳入同一个决策流程。这种方法可以降低引入替代供应商时出现下游意外情况的风险，并透过并行测试和文件共用来加快核准速度。

投资分析和应用支援能力会带来丰厚的回报。建立内部或合作实验室，用于流变学、粒径分布和压实分析，可以快速进行等效性测试，并加速规模化生产。将技术投资与基于情境的采购计画结合，评估供应商能力、双重采购方案和物流应急措施，可以缓解贸易政策波动和产能限制的影响。这些综合措施有助于在保持配方性能的同时，维持供应的连续性。

采用奖励透明度和持续改进的供应商合作模式。优先考虑那些发布高品质文件、参与联合开发计划并致力于永续性改进的供应商。尽可能协商灵活的商业条款，其中包含品质保证、合约变更控制和联合规划条款。最后，在产品开发策略的早期阶段就考虑粘合剂，以充分利用配方协同效应，减少后期替代，并确保供应链决策支援产品的长期性能和合规性目标。

透过结合相关人员访谈、技术文献综合和供应商能力评估的混合研究途径，获得可靠的见解。

本研究综合分析基于一套结构化的方法，整合了相关人员访谈、技术文献综述和供应商能力评估，从而提供严谨且可操作的分析。主要资讯来源包括与配方科学家、采购负责人和法规专家的讨论，他们的营运见解有助于解读材料功能、合格困难和筹资策略。这些定性资讯与黏合剂化学的技术文献、生产案例研究和官方法规指南进行了交叉比对，以确保研究结果建立在坚实的技术基础之上。

供应商能力评估着重于生产流程、品管体係以及应用支援服务的可用性。在适用情况下，我们会审查审核和製造商文檔，以检验可追溯性实务以及是否符合相关药典标准。该调查方法还纳入了情境分析，以探讨供应中断或政策变化对营运的影响，并提案切实可行的缓解措施。

在整个过程中，我们将重点放在可重复的评估标准，包括功能绩效指标、监管准备指标和供应链韧性指标。这种混合方法确保了所提出的见解既具有技术上的合理性，又能直接应用于商业性决策和製剂开发规划。

最终整合方案将粘合剂辅料定位为跨职能优先事项，连接製剂性能、筹资策略和供应链弹性。

粘合剂辅料是一类策略性材料，其选择会影响配方性能、製程效率、法规遵循和供应链韧性。此外，营养保健品级和药品级辅料的差异决定了其所需的文件和供应商资质要求也不同。企业若能将技术评估与筹资策略和法规计画结合，便可降低风险并加快产品上市速度。

不断变化的市场环境要求配方团队和采购团队之间加强协作，增加对分析能力的投入，并积极主动地与供应商沟通，并专注于透明度和产能保障。区域动态和贸易政策的转变进一步凸显了多元化筹资策略和基于情境的库存规划的必要性。综上所述，这些结论指向一个切实可行的目标：将黏合剂辅料视为跨职能部门的优先事项，而非单纯的商品采购，并在产品开发流程的早期阶段就对其进行评估，以确保其性能和供应的连续性。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 对源自可再生资源的天然聚合物粘合剂的需求不断增长，以满足永续配方的需求。
  • 喷雾干燥淀粉作为多功能粘合剂在直接压片中的应用日益广泛。
  • 人们对微晶纤维素在高速片剂生产中提高可压缩性的兴趣日益浓厚
  • 开发多功能共加工粘合剂辅料以取代片剂中的单功能粘合剂
  • 将有机酸改质粘合剂整合到片剂中，以改善片剂的崩坏和溶出性能。
  • 扩大不含染料和过敏原的药用粘合剂配方，以满足不断变化的监管要求
  • 改进粘合剂和辅料，以实现製药生产线上的连续生产
  • 利用奈米工程粘合剂辅料优化控制释放片剂药物释放曲线的研究与开发正在兴起。
  • 预测粘合剂性能的建模软体的出现，简化了配方开发流程，减少了试验失败。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章粘合剂添加剂市场（按类型划分）

  • 海藻酸盐
  • 纤维素衍生物
  • 口香糖和凝胶
  • 聚乙烯吡咯烷酮
  • 淀粉
  • 醣类和多元醇

第九章 按应用分類的粘合剂添加剂市场

  • 直接压片
  • 干式製粒
  • 口服固体製剂
    • 胶囊
    • 药片
  • 湿式製粒

第十章 依形态分類的粘合剂市场

  • 干燥黏合剂
  • 液体黏合剂

第十一章粘合剂市场（按等级划分）

  • 营养补充品
  • 製药

第十二章 各地区粘合剂添加剂市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章粘合剂添加剂市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国粘合剂添加剂市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • International Flavors & Fragrances Inc.
    • Roquette Freres SA
    • Ashland Inc.
    • BASF SE
    • JRS Pharma GmbH & Co. KG
    • DFE Pharma NV
    • Merck KGaA
    • Shin-Etsu Chemical Co., Ltd.
    • Kerry Group plc
    • Ingredion Incorporated
Product Code: MRR-742BD517BD05

The Binders Excipients Market is projected to grow by USD 4.24 billion at a CAGR of 9.93% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.99 billion
Estimated Year [2025] USD 2.18 billion
Forecast Year [2032] USD 4.24 billion
CAGR (%) 9.93%

A strategic orientation to binder excipients that outlines their multifaceted roles in product performance, manufacturability, and supply chain resilience

Binder excipients underpin the mechanical integrity, manufacturability, and patient performance of oral solid dosage forms and a growing range of nutraceutical products. These materials function beyond simple adhesion; they mediate powder flow, compressibility, disintegration behavior, and stability under varied processing conditions. With formulation complexity increasing and process intensification becoming standard, understanding binder functionality is essential for both formulation scientists and sourcing professionals.

Across pharmaceutical and nutraceutical contexts, binders influence formulation selection from early development through commercialization. The choice between polymeric binders and traditional starch-based systems drives downstream process settings, tableting speeds, and even coating behavior. Consequently, binder selection has ripple effects across quality by design frameworks, regulatory strategy, and cost management. Practitioners must therefore evaluate binders not only by composition and grade but by how they interact with active ingredients, excipients, and processing technologies.

Recent shifts in material science and regulatory expectations have intensified scrutiny on excipient characterization, traceability, and supplier governance. Simultaneously, manufacturing paradigms such as continuous processing and direct compression place new functional demands on binder performance. This introduction frames binder excipients as a strategic category whose selection and supply chain management materially affect product performance, time to market, and operational resilience.

How technological innovation, regulatory transparency, and supply chain resilience are jointly reshaping binder excipient selection and supplier strategies

The landscape for binder excipients is experiencing transformative shifts driven by technological, regulatory, and supply chain dynamics. Advances in polymer chemistry and functional starch modification are enabling binders that deliver tailored release profiles, improved compressibility, and reduced lubricant sensitivity. At the same time, manufacturing innovation-such as continuous direct compression and high-throughput tableting-demands binders with predictable rheology and robust process windows.

Regulatory expectations are shifting toward greater transparency and traceability for excipient sourcing, prompting suppliers to invest in enhanced documentation, controlled material attributes, and third-party testing. This trend is paralleled by increasing scrutiny of impurity profiles and leachables, which in turn has accelerated the adoption of more rigorously characterized grades for pharmaceutical applications. As a result, the boundary between pharmaceutical-grade and nutraceutical-grade excipients is becoming more defined in practice, even if regulatory regimes differ by jurisdiction.

Supply chain resilience has emerged as a decisive factor. Disruptions have highlighted the need for diversified sourcing strategies and supplier risk assessment frameworks that extend beyond price and lead time. Companies are re-evaluating contracts, qualifying secondary sources, and seeking longer-term strategic partnerships with suppliers that can demonstrate capacity, quality systems, and logistical reliability. These combined forces are reshaping how formulators and procurement teams evaluate binder choices, prioritizing functional performance alongside regulatory readiness and supply continuity.

Assessing how tariff adjustments and trade policy shifts reshape sourcing behaviors, supplier diversification, and inventory strategies across binder supply chains

The introduction of tariff measures and trade policy adjustments can have wide-ranging effects on the binder excipient ecosystem, affecting raw material costs, supplier sourcing strategies, and inventory planning. Tariffs tend to raise the cost base for imported excipients, which in turn pressures manufacturers to reassess supplier networks and examine local sourcing alternatives. When customs duties increase unpredictably, contract terms, lead times, and total landed cost calculations require more frequent revision.

Manufacturers often respond to tariff-driven cost pressures by diversifying supplier footprints to include domestic producers or free trade zone partners that mitigate duty exposure. This reconfiguration can improve resilience but may also introduce variability in excipient attributes if alternate suppliers use different production technologies or raw materials. As a result, formulation teams must invest in bridging development activities and equivalence testing to ensure that substitutions do not compromise tablet integrity, dissolution performance, or stability.

Tariffs also influence inventory strategies. Companies may opt for strategic stockpiling of critical binder grades to buffer against short-term cost volatility, but this creates additional working capital and storage considerations as well as shelf-life management obligations. In parallel, procurement functions are renegotiating long-term agreements and exploring hedging mechanisms with suppliers to smooth the impact of tariff unpredictability. These cumulative adjustments highlight the need for integrated commercial and technical decision-making to preserve both product quality and margin under shifting trade conditions.

Integrated segmentation insights that align binder chemistries, application methodologies, physical forms, and quality grades to support formulation and sourcing decisions

A nuanced understanding of binder segmentation is essential for aligning formulation goals, manufacturing platforms, and regulatory compliance. When considering type-based selection, formulators evaluate materials such as alginates, cellulose derivatives, gums and gels, polyvinylpyrrolidone, starch, and sugars and polyols for their distinct functional attributes. Alginates offer unique hydration and gelation behaviors beneficial for controlled-release applications, while cellulose derivatives are valued for consistent compressibility and film-forming capacity. Gums and gels can impart viscosity and binding under moist granulation regimes, and polyvinylpyrrolidone provides strong dry binding and solution-binding properties that suit diverse manufacturing methods. Starch remains a versatile baseline binder with clear advantages in cost and biodegradability, whereas sugars and polyols often serve dual roles as binders and taste-modifying excipients in certain dose forms.

Application-driven segmentation influences both selection and performance expectations. Direct compression demands binders that support flow, compressibility, and tablet strength without additional granulation steps, whereas dry granulation requires materials that withstand compaction forces and minimize friability. Wet granulation introduces a separate set of criteria where the binder's solubility, drying profile, and interaction with active ingredients affect granule quality and downstream processing. Oral solid dosage forms span capsule and tablet presentations, each with unique disintegration and stability requirements; capsule formulations place greater emphasis on binder interaction with fill material and capsule shell integrity, while tablet formats focus on compaction dynamics and coating compatibility.

Form selection-dry binder versus liquid binder-further shapes development pathways and equipment choices. Dry binders integrate readily into powder blends and simplify handling for continuous processing, but they may require careful control of particle size and moisture content. Liquid binders are often used in wet granulation to achieve rapid granule formation and uniform distribution, though they introduce solvent handling and drying considerations that can affect process throughput and cost. Finally, grade differentiation between nutraceutical and pharmaceutical influences documentation, quality systems, and supplier qualification burdens. Pharmaceutical-grade binders necessitate tighter control over impurities, robust traceability, and adherence to pharmacopoeial standards, while nutraceutical-grade materials may permit more flexibility but still require consistent functional performance for consumer-facing products.

Transitioning across these segmentation axes requires cross-functional collaboration. Formulation scientists must work alongside procurement, quality, and regulatory teams to ensure that binder selection meets technical objectives while aligning with supplier capabilities and compliance commitments. Equivalence studies, small-scale process characterization, and documented supplier audits are practical tools to manage the intersection of type, application, form, and grade in a cohesive development and manufacturing plan.

Regional dynamics that shape binder sourcing, regulatory conformity, and manufacturing partnerships across the Americas, Europe Middle East Africa, and Asia-Pacific markets

Regional dynamics exert a strong influence on binder sourcing, regulatory expectations, and manufacturing strategy. In the Americas, established pharmaceutical clusters combine advanced manufacturing capabilities with mature regulatory frameworks, enabling close collaboration between suppliers and contract manufacturers. North American markets emphasize supply chain transparency, rigorous quality management systems, and a preference for suppliers that can demonstrate long-term capacity and technical support. Latin American countries present different dynamics, with increasing local manufacturing and a growing emphasis on affordability and supply security, prompting multinational companies to adapt procurement and distribution strategies accordingly.

Across Europe, the Middle East & Africa, regulatory harmonization and stringent pharmacopoeial standards set high bars for excipient documentation and traceability. European markets often lead in the adoption of sustainability criteria and stricter impurity controls, influencing supplier investments in greener manufacturing practices and enhanced analytical characterization. In parts of the Middle East and Africa, reliance on imports for specialized binder grades continues, but regional hubs and free trade zones are emerging that can reduce lead times and tariff exposure for nearby markets. These regional nuances require suppliers and manufacturers to calibrate their technical dossiers and logistical arrangements to meet distinctive regulatory and commercial expectations.

Asia-Pacific combines diverse market maturity levels with large-scale manufacturing capacity and innovation in raw material processing. Major producers of traditional and novel binder chemistries are located in this region, supplying global supply chains with cost-competitive options while also accelerating local innovation in biopolymers and modified starch technologies. Regional regulatory frameworks vary considerably, and companies operating across Asia-Pacific must navigate differing registration requirements, standards, and import controls. Together, these regional characteristics shape how companies prioritize supplier qualification, technical support, and local manufacturing partnerships to achieve both cost efficiency and regulatory compliance.

Competitive supplier strategies that combine technical co-development, stringent quality systems, and sustainability credentials to win formulation and procurement partnerships

Competitive dynamics among binder suppliers now centers on a combination of technical service, quality assurance, and supply reliability. Leading manufacturers differentiate through investments in analytical capabilities, such as particle characterization, rheological profiling, and stability testing, which enable them to support complex formulation development and equivalence demonstrations. Suppliers that offer application laboratories and co-development services help customers shorten development cycles and reduce risk when qualifying new materials or switching sources.

Quality systems and regulatory documentation are critical competitive levers. Firms that maintain comprehensive certificates of analysis, robust change control processes, and demonstrable supplier audits tend to win longer-term contracts with pharmaceutical customers who require traceability and compliance. In parallel, companies that can provide multiple grades-spanning nutraceutical to pharmaceutical-with clear quality delineation are well-positioned to serve diverse client segments. Strategic partnerships and long-term supply agreements are increasingly common, reflecting customer demand for predictable lead times and contingency planning.

Sustainability and corporate responsibility are emerging differentiators. Suppliers that adopt greener manufacturing processes, reduce solvent use, and demonstrate responsible sourcing of botanical and starch feedstocks appeal to customers who incorporate environmental criteria into procurement decisions. As procurement organizations elevate supplier risk management and environmental considerations, firms that can align technical performance with sustainability credentials secure competitive advantage. Moreover, the ability to scale production to support both small-batch innovation work and high-volume commercial supply remains a critical capability for suppliers seeking to serve global customers.

Actionable strategic steps for leaders to align technical capability, supplier diversification, and governance frameworks to secure binder availability and product quality

Industry leaders should prioritize an integrated strategy that aligns technical development, supplier diversification, and regulatory readiness. Begin by implementing a cross-functional binder governance framework that brings formulation scientists, quality assurance, procurement, and regulatory affairs into a single decision-making loop. This approach reduces the risk of downstream surprises when substitute suppliers are introduced and accelerates qualification timelines through concurrent testing and documentation sharing.

Investments in analytical and application support capabilities pay dividends. Establishing in-house or collaborative labs for rheology, particle size distribution, and compaction analysis enables rapid equivalence testing and accelerates scale-up. Pair technical investments with scenario-based procurement planning that evaluates supplier capacity, dual-sourcing options, and logistics contingencies to mitigate trade policy volatility and capacity constraints. These combined measures help maintain continuity of supply while preserving formulation performance.

Adopt a supplier engagement model that rewards transparency and continuous improvement. Prefer suppliers who publish robust quality documentation, participate in joint development projects, and commit to sustainability improvements. Where possible, negotiate flexible commercial terms that incorporate quality guarantees, contractual change control, and collaborative planning provisions. Finally, incorporate binder considerations early in product development strategies to exploit formulation synergies, reduce late-stage substitutions, and ensure that supply chain decisions support long-term product performance and compliance objectives.

A mixed-method research approach combining stakeholder interviews, technical literature synthesis, and supplier capability assessments for dependable insights

This research synthesis relies on a structured methodology that integrates primary stakeholder interviews, technical literature review, and supplier capability assessments to produce a rigorous, actionable analysis. Primary inputs included discussions with formulation scientists, procurement leads, and regulatory specialists whose operational insights informed the interpretation of material functionality, qualification hurdles, and sourcing strategies. These qualitative inputs were triangulated with technical literature on binder chemistry, manufacturing case studies, and public regulatory guidance to ensure findings are grounded in robust technical context.

Supplier capability assessments focused on production processes, quality management systems, and the availability of application support services. Where applicable, audits and manufacturer documentation were reviewed to verify traceability practices and conformity with relevant pharmacopoeial standards. The methodology also incorporated scenario analysis to explore the operational impacts of supply disruptions and policy shifts, enabling the development of practical mitigation recommendations.

Throughout the process, an emphasis was placed on reproducible evaluation criteria such as functional performance metrics, regulatory readiness indicators, and supply chain resilience measures. This mixed-method approach ensures that the insights presented are both technically defensible and directly applicable to commercial decision-making and formulation development planning.

Concluding synthesis that positions binder excipients as a cross-functional priority linking formulation performance, procurement strategy, and supply chain resilience

Binder excipients represent a strategic category whose selection affects formulation performance, process efficiency, regulatory compliance, and supply chain resilience. Functional differentiation across binder chemistries and forms creates meaningful implications for manufacturing platforms such as direct compression, wet granulation, and dry granulation, while grade differentiation between nutraceutical and pharmaceutical uses alters documentation and supplier qualification demands. Companies that align technical evaluation with procurement strategy and regulatory planning can reduce risk and accelerate time to market.

The evolving landscape calls for closer collaboration between formulation and procurement teams, deeper investment in analytical capabilities, and proactive supplier engagement that emphasizes transparency and capacity assurance. Regional dynamics and trade policy shifts further underline the necessity of diversified sourcing strategies and scenario-based inventory planning. Taken together, these conclusions point to a single practical imperative: treat binder excipients as a cross-functional priority rather than a purely commodity purchase, and embed their evaluation early in product development workflows to secure performance and supply continuity.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising demand for natural polymer binders derived from renewable resources for sustainable formulations
  • 5.2. Increasing adoption of spray-dried starch as multifunctional binder in direct compression tablet processes
  • 5.3. Growing focus on microcrystalline cellulose variants with enhanced compressibility in high-speed tablet manufacturing
  • 5.4. Development of multifunctional coprocessed binder excipients to replace single-function binding agents in tablets
  • 5.5. Integration of organic acid modified binder excipients to improve tablet disintegration and dissolution performance
  • 5.6. Expansion of pharmaceutical dye-free and allergen-free binder formulations to meet evolving regulatory requirements
  • 5.7. Advancement of binder excipient formulations enabling continuous manufacturing in pharmaceutical production lines
  • 5.8. Surge in R&D for nanoengineered binder excipients to optimize drug release profiles in controlled release tablets
  • 5.9. Emergence of predictive modeling software for binder performance to streamline formulation development and reduce trial failures

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Binders Excipients Market, by Type

  • 8.1. Alginates
  • 8.2. Cellulose Derivatives
  • 8.3. Gums And Gels
  • 8.4. Polyvinylpyrrolidone
  • 8.5. Starch
  • 8.6. Sugars And Polyols

9. Binders Excipients Market, by Application

  • 9.1. Direct Compression
  • 9.2. Dry Granulation
  • 9.3. Oral Solid Dosage
    • 9.3.1. Capsule
    • 9.3.2. Tablet
  • 9.4. Wet Granulation

10. Binders Excipients Market, by Form

  • 10.1. Dry Binder
  • 10.2. Liquid Binder

11. Binders Excipients Market, by Grade

  • 11.1. Nutraceutical
  • 11.2. Pharmaceutical

12. Binders Excipients Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Binders Excipients Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Binders Excipients Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. International Flavors & Fragrances Inc.
    • 15.3.2. Roquette Freres SA
    • 15.3.3. Ashland Inc.
    • 15.3.4. BASF SE
    • 15.3.5. JRS Pharma GmbH & Co. KG
    • 15.3.6. DFE Pharma N.V.
    • 15.3.7. Merck KGaA
    • 15.3.8. Shin-Etsu Chemical Co., Ltd.
    • 15.3.9. Kerry Group plc
    • 15.3.10. Ingredion Incorporated

LIST OF FIGURES

  • FIGURE 1. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS BINDERS EXCIPIENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BINDERS EXCIPIENTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. BINDERS EXCIPIENTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BINDERS EXCIPIENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY ALGINATES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY ALGINATES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY ALGINATES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY ALGINATES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY ALGINATES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY ALGINATES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY GUMS AND GELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY GUMS AND GELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY GUMS AND GELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY GUMS AND GELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY GUMS AND GELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY GUMS AND GELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY POLYVINYLPYRROLIDONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY POLYVINYLPYRROLIDONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY POLYVINYLPYRROLIDONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY POLYVINYLPYRROLIDONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY POLYVINYLPYRROLIDONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY POLYVINYLPYRROLIDONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY STARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY STARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY STARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY STARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY STARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY STARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYOLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYOLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYOLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYOLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYOLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYOLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DIRECT COMPRESSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DIRECT COMPRESSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DIRECT COMPRESSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DIRECT COMPRESSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DIRECT COMPRESSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DIRECT COMPRESSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DRY GRANULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DRY GRANULATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DRY GRANULATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DRY GRANULATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DRY GRANULATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DRY GRANULATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY CAPSULE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY CAPSULE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY CAPSULE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY CAPSULE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY CAPSULE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY TABLET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY TABLET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY TABLET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY TABLET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY WET GRANULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY WET GRANULATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY WET GRANULATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY WET GRANULATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY WET GRANULATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY WET GRANULATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DRY BINDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DRY BINDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DRY BINDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DRY BINDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DRY BINDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY DRY BINDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY LIQUID BINDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY LIQUID BINDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY LIQUID BINDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY LIQUID BINDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY LIQUID BINDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY LIQUID BINDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY NUTRACEUTICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY NUTRACEUTICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY NUTRACEUTICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY NUTRACEUTICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY NUTRACEUTICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY NUTRACEUTICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY PHARMACEUTICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY PHARMACEUTICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY PHARMACEUTICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY PHARMACEUTICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. AMERICAS BINDERS EXCIPIENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 114. AMERICAS BINDERS EXCIPIENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 115. AMERICAS BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 117. AMERICAS BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 119. AMERICAS BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 120. AMERICAS BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 121. AMERICAS BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 122. AMERICAS BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 123. AMERICAS BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. NORTH AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 128. NORTH AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 130. NORTH AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 132. NORTH AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 134. NORTH AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 136. NORTH AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. LATIN AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. LATIN AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 142. LATIN AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 144. LATIN AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 146. LATIN AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 148. LATIN AMERICA BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 161. EUROPE BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. EUROPE BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 167. EUROPE BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 168. EUROPE BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. MIDDLE EAST BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. MIDDLE EAST BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. MIDDLE EAST BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 180. MIDDLE EAST BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 182. MIDDLE EAST BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 184. MIDDLE EAST BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 185. AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 190. AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 191. AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 192. AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 193. AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 194. AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 195. AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 196. AFRICA BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. ASEAN BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. ASEAN BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. ASEAN BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. ASEAN BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. ASEAN BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 216. ASEAN BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 217. ASEAN BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 218. ASEAN BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 219. ASEAN BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 220. ASEAN BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 221. ASEAN BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 222. ASEAN BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 223. GCC BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GCC BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GCC BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. GCC BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. GCC BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. GCC BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 229. GCC BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 230. GCC BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 231. GCC BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 232. GCC BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 233. GCC BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 234. GCC BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPEAN UNION BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPEAN UNION BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPEAN UNION BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPEAN UNION BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPEAN UNION BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPEAN UNION BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 247. BRICS BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. BRICS BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. BRICS BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. BRICS BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. BRICS BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. BRICS BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 253. BRICS BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 254. BRICS BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 255. BRICS BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 256. BRICS BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 257. BRICS BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 258. BRICS BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 259. G7 BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. G7 BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. G7 BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. G7 BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. G7 BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 264. G7 BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 265. G7 BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 266. G7 BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 267. G7 BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 268. G7 BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 269. G7 BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 270. G7 BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 271. NATO BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. NATO BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. NATO BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. NATO BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. NATO BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. NATO BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 277. NATO BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 278. NATO BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 279. NATO BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 280. NATO BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 281. NATO BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 282. NATO BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL BINDERS EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. UNITED STATES BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. UNITED STATES BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. UNITED STATES BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. UNITED STATES BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 289. UNITED STATES BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 290. UNITED STATES BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 291. UNITED STATES BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 292. UNITED STATES BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 293. UNITED STATES BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 294. UNITED STATES BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 295. CANADA BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. CANADA BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. CANADA BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 298. CANADA BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 299. CANADA BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 300. CANADA BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 301. CANADA BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 302. CANADA BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 303. CANADA BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 304. CANADA BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 305. MEXICO BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. MEXICO BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 307. MEXICO BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 308. MEXICO BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 309. MEXICO BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 310. MEXICO BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 311. MEXICO BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 312. MEXICO BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 313. MEXICO BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 314. MEXICO BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 315. BRAZIL BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. BRAZIL BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. BRAZIL BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 318. BRAZIL BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 319. BRAZIL BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 320. BRAZIL BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 321. BRAZIL BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 322. BRAZIL BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 323. BRAZIL BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 324. BRAZIL BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 325. UNITED KINGDOM BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 326. UNITED KINGDOM BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 327. UNITED KINGDOM BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 328. UNITED KINGDOM BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 329. UNITED KINGDOM BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 330. UNITED KINGDOM BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 331. UNITED KINGDOM BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 332. UNITED KINGDOM BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 333. UNITED KINGDOM BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 334. UNITED KINGDOM BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 335. GERMANY BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 336. GERMANY BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 337. GERMANY BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 338. GERMANY BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 339. GERMANY BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 340. GERMANY BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 341. GERMANY BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 342. GERMANY BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 343. GERMANY BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2018-2024 (USD MILLION)
  • TABLE 344. GERMANY BINDERS EXCIPIENTS MARKET SIZE, BY GRADE, 2025-2032 (USD MILLION)
  • TABLE 345. FRANCE BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 346. FRANCE BINDERS EXCIPIENTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 347. FRANCE BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 348. FRANCE BINDERS EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 349. FRANCE BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 350. FRANCE BINDERS EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 351. FRANCE BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 352. FRANCE BINDERS EXCIPIENTS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 353. FRANCE BINDE